Find your path to David
About
Venture Partner since fall 2021 who previously worked in Global BD at GSK on immunology opportunities and at Portola Pharmaceuticals and DNAX Research. He holds a PhD in Molecular Oncology from the Imperial Cancer Research Fund.
Experience
- Samsara BioCapitalVenture Partnercurrent2021 — present
- GSKBusiness Development Director, West Coast2019 — 2021SF Bay Area
- GlaxoSmithKlineExecutive Director & E-i-R2013 — 2019SF Bay Area
- Portola PharmaceuticalsDirector Biology2011 — 2013
- MerckSenior Research Fellow2009 — 2011
- Schering Plough BiopharmaResearch Fellow2005 — 2009
- Schering Plough Biopharma/DNAX Research InstituteSenior Principal Scientist2000 — 2005
Skills & more
OncologyDrug DiscoveryLife SciencesTherapeuticsPharmaceuticalsPharmaceutical DevelopmentProduct DevelopmentPharmaceutical IndustryDrug DevelopmentLifesciencesBiochemistryAssay Development
+8 more
Biomarker DiscoveryBiotechnologyImmunologyClinical DevelopmentBiomarkersBiopharmaceuticalsMolecular BiologyCell CultureFrom David's professional profile.
Colleagues at Samsara BioCapital
Abe Bassan
Principal at Samsara BioCapital
Alan Eisenberg
Venture Partner at Samsara BioCapital
Andrew Walker
Assistant Controller at Samsara BioCapital
Betsy Santos
Venture Partner, Chief People Officer at Samsara BioCapital
Carolyn Nguyen
Deputy General Counsel at Samsara BioCapital
Clara Dong
Senior Associate at Samsara BioCapital
Connie Su
Senior Fund Accountant at Samsara BioCapital
Cory Freedland
Investor at Samsara BioCapital
Frequently asked questions
- Who is David Parry?
- Venture Partner since fall 2021 who previously worked in Global BD at GSK on immunology opportunities and at Portola Pharmaceuticals and DNAX Research. He holds a PhD in Molecular Oncology from the Imperial Cancer Research Fund.
- Where does David Parry work?
- David Parry is Venture Partner at Samsara BioCapital.
- Where did David Parry go to school?
- David Parry studied at Imperial Cancer Research Fund, London (Ph.D., Molecular Oncology and Mammalian Cell Cycle Control); University of Manchester Institute of Science and Technology (B.Sc (Hons), 1st Class, Biochemistry and Applied Molecular Biology); The University of Manchester.
Same school
Also attended The University of Manchester342
Joel NoyceInvestor at Moonfire VenturesJames BraithwaiteFinancial Controller at NorthzoneFreya Svedberg-KeatingInvestor at MedicxiAndy LeaverOperating Partner at Notion CapitalSimon SegarsExecutive Advisor at Black Opal VenturesHonor de WintonExecutive Assistant at Giant Ventures Global Llp
+ 336 more
Shared employers
Also worked at GSK278
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 272 more
Also worked at Portola Pharmaceuticals6
Tao FuVenture Partner at Frazier Life SciencesPamela ConleyFounder at NuvigAlex GoldChief Medical Officer at BerenTed W. LoveExecutive Officer, Director at Global Blood TherapeuticsJeet MahalExecutive Officer, Director at Jasper TherapeuticsDanielle Olander-MoghadassianConsulting Chief Human Resources Officer at CytomX
Also worked at Merck262
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures
+ 256 more





























